CVS Health is still a cash flow machine.
An owner of radio stations, a homebuilder and a wellness company still offer value even after the broader market's run to record highs.
CVS is setting up an anticipated new stock trajectory for investors.
The rule: Never pay more than a stock's normalized valuation when making a new commitment.
We also dissect the S&P 500's record run, check out China's latest economic data and take a skeptical glance at an idea floated by a couple Fed officials.
The fear will subside around health care stocks, and here is why.
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
Talk among a mammoth field of presidential candidates about drug price controls and an expansion of Medicare isn't helping biotech and health care stocks.
Insurance companies would have their claws in any potential new healthcare law so deep, the law will have slash marks on it.
Especially when healthcare CEOs discus political issues with analysts and reporters.